Drew Moghanaki, at , shared on Twitter:
“Here is a trio of ongoing adjuvant studies for patients with stage IA NSCLC. If either is positive, patients with stage IA may soon have to choose between Surgery+Observe and SBRT+ICI.”
Source: Drew Moghanaki/Twitter